Cooperative Studies Program (CSP) #572: A Study of Serious Mental Illness in Veterans as a Pathway to personalized medicine in Schizophrenia and Bipolar Illness
- PMID: 34222732
- PMCID: PMC8247126
- DOI: 10.1016/j.pmip.2021.100078
Cooperative Studies Program (CSP) #572: A Study of Serious Mental Illness in Veterans as a Pathway to personalized medicine in Schizophrenia and Bipolar Illness
Abstract
Background: Personalization of psychiatric treatment includes treatment of symptoms, cognition and functional deficits, suicide, and medical co-morbidities. VA Collaborative Study 572 examined a large sample of male and female veterans with schizophrenia (n=3,942) and with bipolar disorder (n=5,414) with phenotyping and genomic analyses. We present the results to date and future directions.
Methods: All veterans received a structured diagnostic interview and assessments of suicidal ideation and behavior, PTSD, and health. Veterans with schizophrenia were assessed for negative symptoms and lifetime depression. All were assessed with a cognitive and functional capacity assessment. Data for genome wide association studies were collected. Controls came from the VA Million Veteran Program.
Results: Suicidal ideation or behavior was present in 66%. Cognitive and functional deficits were consistent with previous studies. 40% of the veterans with schizophrenia had a lifetime major depressive episode and PTSD was present in over 30%. Polygenic risk score (PRS) analyses indicated that cognitive and functional deficits overlapped with PRS for cognition, education, and intelligence in the general population and PRS for suicidal ideation and behavior correlated with previous PRS for depression and suicidal ideation and behavior, as did the PRS for PTSD.
Discussion: Results to date provide directions for personalization of treatment in SMI, veterans with SMI, and veterans in general. The results of the genomic analyses suggest that cognitive deficits in SMI may be associated with general population features. Upcoming genomic analyses will reexamine the issues above, as well as genomic factors associated with smoking, substance abuse, negative symptoms, and treatment response.
Figures


Similar articles
-
Suicidal ideation and behavior in US veterans with schizophrenia or bipolar disorder.J Psychiatr Res. 2018 Jul;102:216-222. doi: 10.1016/j.jpsychires.2018.04.014. Epub 2018 Apr 21. J Psychiatr Res. 2018. PMID: 29698922
-
Genome-wide association study of cognitive performance in U.S. veterans with schizophrenia or bipolar disorder.Am J Med Genet B Neuropsychiatr Genet. 2020 Apr;183(3):181-194. doi: 10.1002/ajmg.b.32775. Epub 2019 Dec 24. Am J Med Genet B Neuropsychiatr Genet. 2020. PMID: 31872970
-
Incidence and antecedents of emergent suicidal ideation and behavior among Veterans with serious mental illness receiving intensive case management.J Psychiatr Res. 2025 Jan;181:607-613. doi: 10.1016/j.jpsychires.2024.12.018. Epub 2024 Dec 22. J Psychiatr Res. 2025. PMID: 39740616
-
Comparing Medications Added to a Serotonin Reuptake Inhibitor to Treat Patients with PTSD [Internet].Washington (DC): Patient-Centered Outcomes Research Institute (PCORI); 2021 May. Washington (DC): Patient-Centered Outcomes Research Institute (PCORI); 2021 May. PMID: 38556975 Free Books & Documents. Review.
-
Prevention of suicide and attempted suicide in Denmark. Epidemiological studies of suicide and intervention studies in selected risk groups.Dan Med Bull. 2007 Nov;54(4):306-69. Dan Med Bull. 2007. PMID: 18208680 Review.
Cited by
-
Using Real-World Data on Depression from EHR-based Research Networks: A Scoping Review.Res Sq [Preprint]. 2025 Aug 5:rs.3.rs-7272352. doi: 10.21203/rs.3.rs-7272352/v1. Res Sq. 2025. PMID: 40799756 Free PMC article. Preprint.
References
-
- Cross-Disorder Group of the Psychiatric Genomics Consortium. 2019. Electronic address: plee0@mgh.harvard.edu; Cross-Disorder Group of the Psychiatric Genomics Consortium. Genomic Relationships, Novel Loci, and Pleiotropic Mechanisms across Eight Psychiatric Disorders. Cell. 179(7):1469–1482.e11. doi:10.1016/j.cell.2019.11.020 - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources